Carrie Brownstein

Insider Reports History

Location
Austin, TX
Signature
/s/ Andrew R. Neill, Attorney-in-Fact for Carrie Brownstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carrie Brownstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Medical Officer Common Stock 105,685 $1,087,456 $10.29 04 Oct 2023 Direct
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 33,150 14 Jul 2025 Direct

Insider Reports Filed by Carrie Brownstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STTK Shattuck Labs, Inc. 14 Jul 2025 1 $0 4 Director 16 Jul 2025, 16:13
STTK Shattuck Labs, Inc. 21 Jun 2024 1 $0 4 Director 21 Jun 2024, 17:59
ZNTL Zentalis Pharmaceuticals, Inc. 04 Oct 2023 2 -$207,298 4 Chief Medical Officer 06 Oct 2023, 19:19
STTK Shattuck Labs, Inc. 26 May 2023 1 $0 4 Director 31 May 2023, 16:36
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2023 2 $0 4 Chief Medical Officer 01 Feb 2023, 18:06
ZNTL Zentalis Pharmaceuticals, Inc. 03 Oct 2022 3 $0 4 Chief Medical Officer 03 Oct 2022, 18:37
ZNTL Zentalis Pharmaceuticals, Inc. 03 Oct 2022 0 $0 3 Chief Medical Officer 03 Oct 2022, 18:35
STTK Shattuck Labs, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:31
STTK Shattuck Labs, Inc. 12 Nov 2021 1 $0 4 Director 17 Nov 2021, 15:10
STTK Shattuck Labs, Inc. 22 Oct 2021 0 $0 3 Director 17 Nov 2021, 15:05